Optiflow™
nasal high flow
therapy

Proven* respiratory support

                  *A review of studies comprising the body of NHF evidence found the majority used F&P Optiflow™ systems

 

 



High flow nasal cannula (HFNC), high flow therapy (HFT), high flow oxygen/therapy (HFO/T), nasal high flow (NHF), high flow nasal prongs (HFNP), high flow oxygen (HFO), humidified high flow nasal cannula (HHFNC), heated, humidified high flow nasal cannula (HHHFNC), humidified high flow therapy (HHFT), nasal insufflation or just plain high flow (HF).

While many terms are used for this therapy, one name stands out as the way to deliver it: Optiflow NHF therapy

Optiflow NHF therapy from Fisher & Paykel Healthcare is at the forefront of its field, featuring in hundreds of publications and prestigious journals such as NEJM and JAMA.

Using Optiflow NHF therapy as a first-line treatment (both pre-intubation and post-extubation) may reduce a patient's escalation "up the acuity curve", resulting in better patient outcomes.

 

 

Clinical Practice Guidelines for Nasal High Flow

 

Current Best Evidence

(Rochwerg et al. 2020. Intensive Care Med.)

This clinical practice guideline (Rochwerg et al. 2020.
Intensive Care Med.) synthesizes current best evidence
into four recommendations for NHF in adult patients.

Visual Abstract

Get a quick overview with our graphic summary of the study.

Acute hypoxemic
respiratory failure

For primary respiratory support compared to COT.
Recommendation made with moderate certainty.


 

 Strong
Recommendation 

Post-operative
 
For primary respiratory support compared to COT in high risk and/or obese patients following cardiac or thoracic surgery.
Recommendation made with moderate certainty.


 Conditional Recommendation 
Peri-intubation
 
For pre-oxygenation prior to in-ICU intubation no recommendation is made compared to COT.
NHF during intubation should be continued for patients who are already receiving NHF.*

 Continue NHF* 
Post-extubation
respiratory failure

 
For post-extubation respiratory support compared to COT following extubation.
Recommendation made with moderate certainty.



 Conditional Recommendation 

*For patients who are already receiving NHF, guideline authors suggest continuing NHF during intubation (conditional recommendation, moderate certainty).

Flow Matters

In this edition of Flow Matters, we take a look at the recommendations, discuss the evidence-practice gap and the economics of NHF as well as determine what NHF technology was used to establish the guidelines.
 

SHARE THIS EDITION

LinkedIn  Twitter



 
Discuss Optiflow High Flow Therapy with us



Optiflow in Practice

Optiflow™ Nasal High Flow at the Royal Berkshire Hospital (Optiflow Page)

A multi-department implementation of Optiflow NHF therapy

This video shows the introduction of the Airvo 2 device across departments of the Royal Berkshire Hospital in Reading, UK. Hospital clinicians talk about the benefits found both to the patients and hospital since its introduction.
Dr. Jean Frat - NHF for post-extubation support (Optiflow Page)

Extubation to Optiflow NHF therapy:
Dr. Hernández

This video depicts extubation to Optiflow NHF therapy, and is based on the procedure used by Dr. Hernández and his colleagues' in the following studies: Hernández et al. JAMA. 2016 (April)1 and Hernández et al. JAMA 2016 (Oct.)2
An Interview with Jean-Pierre Frat

An interview with Dr. Jean-Pierre Frat

Dr. Frat, the chief investigator of the landmark FLORALI study, talks to us about his experience as a researcher and clinician, while reflecting on a decade of using NHF. We discuss the practical application of NHF for multiple applications in Acute Hypoxemic Respiratory Failure.

ROX Index Explained

The ROX index can be used to monitor patients and predict the likelihood of NHF therapy success or failure. 

It combines three common measurements: FiO2, SpO2, and respiratory rate, and it is based on two known facts about sicker patients. 
1.
 They require more oxygen. 
2. They have a higher respiratory rate.

The index has been validated in a multi-center prospective study on 191 patients with pneumonia.*

Read online  Download PDF




 




ROX* Index
Calculator
app

 
Use the ROX Index
Calculator app

to learn about
entering the
parameters
and calculating the
index.




 
 




ROX* Vector
app

 
Use the ROX
Vector app 
to learn
about visualizing trends
in the parameters
over time.




 
Search Optiflow FAQs

 

Apps/PDFs/Videos


ROX Index* Calculator app

Mobile app available for free at the app Store and Google Play.


ROX Vector* app


Mobile app available for free at the app Store and Google Play.

PM-622077_b
Enquire about Optiflow nasal high flow therapy
If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.
Enter security code
 Security code

Want to receive updates?

Sign up to receive email notifications of the latest product and therapy information as well as upcoming events.
 

Sign up here

The outbreak of COVID-19 has impacted healthcare organizations around the world

A resource center has been created to provide affected hospitals and healthcare professionals with information they may need to treat patients when using Fisher & Paykel Healthcare products.
 

View resource center